CAS NO: | 1226549-39-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | EGFR-IN-9 (Compound 8) is a potentEGFRkinaseinhibitor withIC50s of 7 nM, 28 nM for the wild typeEGFRkinase and double mutantEGFRkinase (L858R/T790M). EGFR-IN-9 has antitumor activity[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | EGFR-IN-9 (Compound 8) shows antiproliferative activity in HCC827 lung cancer cell line with an IC50of 8 nM. | ||||||||||||||||
分子量 | 476.53 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C29H24N4O3 | ||||||||||||||||
CAS 号 | 1226549-39-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(209.85 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |